Seagen CEO takes leave of absence amid domestic violence allegations, shares down 8%GeekWire • 05/09/22
Seagen Inc. (SGEN) CEO Clay Siegall on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 04/28/22
Seagen to Highlight Data from Expanding Oncology Portfolio at 2022 American Society of Clinical Oncology (ASCO) Annual MeetingBusiness Wire • 04/28/22
Biotech giant Seagen reveals plans for 270K square-foot manufacturing facility near SeattleGeekWire • 04/20/22
Seagen Announces Plans to Expand Pacific Northwest Biomanufacturing Capacity to Support Growing Portfolio of Transformative Cancer MedicinesBusiness Wire • 04/20/22
European Commission Approves PADCEV™ (enfortumab vedotin) for Locally Advanced or Metastatic Urothelial CancerPRNewsWire • 04/13/22
Seagen Announces Jury Award in Patent Infringement Case Against Daiichi SankyoBusiness Wire • 04/08/22
Seagen to Highlight Preclinical Data for Enfortumab Vedotin and Two Novel Antibody-Drug Conjugates at AACR Annual MeetingBusiness Wire • 04/08/22
Seagen to Host Conference Call and Webcast Discussion of First Quarter 2022 Financial Results on April 28, 2022Business Wire • 04/07/22
Seagen and Sanofi Announce Collaboration to Develop and Commercialize Multiple Novel Antibody-Drug ConjugatesBusiness Wire • 03/16/22